In the present study, we examined CRYAB and p53 expression in tumor tissues from 103 patients with ovarian cancer via immunohistochemistry (IHC) and investigated the relationship between CRYAB and p53 expression and clinicopathological features. The gene discussed is TP53; the disease is ovarian cancer.